In conclusion, our results strongly indicate that the silencing of Dkk-3 expression by aberrant promoter methylation occurs at an early stage of ALL pathogenesis and plays a role in the outcome of the disease. Here, DKK3 is linked to acute lymphoblastic leukemia.